{"id":31849,"date":"2026-08-20T16:21:44","date_gmt":"2026-08-20T10:51:44","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?p=31849"},"modified":"2026-08-20T16:22:01","modified_gmt":"2026-08-20T10:52:01","slug":"cataract-reimbursement-cut-hurting-asc-margin","status":"publish","type":"post","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/cataract-reimbursement-cut-hurting-asc-margin\/","title":{"rendered":"Is the Cataract Reimbursement Cut Silently Hurting Your ASC Margin?"},"content":{"rendered":"

Yes, in most cases the 2026 cataract reimbursement changes are hurting ASC margin, even when the headline number looks like an increase. The Medicare facility rate for cataract surgery (CPT 66984) rose 3.4% for 2026, but the physician payment for the same procedure fell 11%, and a separate CMS policy quietly reduced indirect practice expense reimbursement for every facility-based procedure.<\/p>\r\n

Add in everyday leakage points, denials, coding gaps, payer underpayments, and unrecovered patient balances, and a facility can post a “win” on paper while its cataract service line actually earns less per case. If your case volume is stable but your net revenue per case keeps drifting down, that gap is worth investigating before your next budget cycle.<\/p>\r\n

Why Cataract Reimbursement Matters More Than the Posted Rate<\/h2>\r\n

Most ASC leaders track the posted Medicare or payer fee schedule and assume that number is what the facility actually collects. In practice, cataract reimbursement is the starting point of the calculation, not the ending point.<\/p>\r\n

The corrected CY 2026 Medicare ASC facility payment for CPT 66984 is $1,255.73, up from $1,214.31 in 2025, per the CMS OPPS\/ASC Final Rule. That is the posted rate. What actually lands on the facility’s books depends on whether the claim was coded correctly, whether prior authorization was in place, whether the payer applied the contracted rate accurately, and whether the patient’s portion was ever collected.<\/p>\r\n

Commercial and Medicare Advantage contracts frequently reference the Medicare fee schedule but apply their own carve-outs, so the same procedure can reimburse differently across payers even within the same facility on the same day.<\/p>\r\n

Meanwhile, under the CY 2026 Physician Fee Schedule Final Rule, the surgeon’s professional payment for CPT 66984 dropped from $521.75 to $462.94, an 11% cut driven by a new 2.5% efficiency adjustment and a policy that cuts indirect practice expense allocation for facility-based services to 50% of the non-facility rate.<\/p>\r\n

That second policy affects far more than cataract surgery. It reduces facility-based reimbursement roughly 10% across many high-volume ASC procedures, which is why this is a margin story for the whole facility, not a single CPT code.<\/p>\r\n

How a Reimbursement Cut Can Compress ASC Margin<\/h2>\r\n

A small percentage change at the top of the fee schedule rarely stays small once it reaches the bottom line, because fixed costs, staffing, supplies, and instrument turnover, don’t shrink along with the reimbursement rate.<\/p>\r\n

As an illustrative example only, consider a six-OR, ophthalmology-heavy ASC running roughly 900 cataract cases a year. The 3.4% facility-rate increase adds an estimated $37,000 in annual facility revenue.<\/p>\r\n

But the 11% physician-side cut removes close to $53,000 from the surgeons billing those same cases, so the combined episode is worth less in 2026 than in 2025 even though the facility remittance alone looks healthier.<\/p>\r\n

This is a modeled example based on the published CMS rate change, not an industry-wide statistic, but it shows why administrators should evaluate the full episode rather than one side of it.<\/p>\r\n

That compression rarely shows up as one obvious number. It shows up as recruitment friction with surgeons, slower block-time scheduling, and a slow drift in per-case yield that compounds across a full year of volume before anyone traces it back to its source.<\/p>\r\n

Cataract Reimbursement: Where Revenue Leakage Usually Happens<\/h2>\r\n

High surgical volume does not guarantee a healthy margin. Most erosion happens in the operational layer between the posted rate and the actual deposit, and it tends to concentrate in a few predictable places.<\/p>\r\n

Coding and documentation gaps are a common starting point. The distinction between CPT 66982 (complex cataract) and CPT 66984 (routine cataract) requires documented complexity factors such as a small pupil, dense cataract, or weak zonules. Billing 66982 without that documentation is one of the most common ophthalmology audit triggers, and it can also trigger downcoding or denial on review.<\/p>\r\n

Lapsed prior authorizations discovered after surgery routinely convert to hard denials. Implant and IOL cost recovery is specific to cataract cases: premium IOLs and several MIGS-adjacent codes are now designated device-intensive, and facilities that don’t tie implant charge capture directly to OR logs under-bill those costs case after case.<\/p>\r\n

Underpayment detection is quieter still; payers sometimes apply the wrong contracted rate, and without systematic payment posting review those underpayments go uncaught. Finally, patient responsibility collection, deductibles and coinsurance never gathered after insurance, is where a meaningful share of technically “earned” revenue is never actually collected.<\/p>\r\n

Revenue Leakage at a Glance<\/h2>\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n
Revenue\/Margin Area<\/strong><\/td>\r\nWhat Can Go Wrong<\/strong><\/td>\r\nMargin Impact<\/strong><\/td>\r\nWhat ASC Should Monitor<\/strong><\/td>\r\n<\/tr>\r\n<\/thead>\r\n
Coding & complexity documentation<\/td>\r\n66982 billed without documented complexity, or under-documented 66984<\/td>\r\nDenials, downcoding, audit risk<\/td>\r\n66982:66984 ratio vs. specialty benchmark<\/td>\r\n<\/tr>\r\n
Prior authorization & eligibility<\/td>\r\nAuthorization lapses or expires before surgery date<\/td>\r\nHard denials, unbillable cases<\/td>\r\nAuthorization status confirmed 48\u201372 hrs pre-op<\/td>\r\n<\/tr>\r\n
Payer contract vs. Medicare rate<\/td>\r\nPayer applies outdated or incorrect contracted rate<\/td>\r\nSilent underpayment per case<\/td>\r\nContracted rate audit on posted payments<\/td>\r\n<\/tr>\r\n
Implant\/IOL cost recovery<\/td>\r\nDevice-intensive codes not tied to OR log implant data<\/td>\r\nUnrecovered implant cost per case<\/td>\r\nImplant charge capture rate<\/td>\r\n<\/tr>\r\n
Patient responsibility collection<\/td>\r\nDeductible\/coinsurance not collected at time of service<\/td>\r\nUncollected earned revenue<\/td>\r\nPoint-of-service collection rate<\/td>\r\n<\/tr>\r\n
Payment posting accuracy<\/td>\r\nUnderpayments posted without variance review<\/td>\r\nRevenue never flagged or appealed<\/td>\r\nUnderpayment\/variance report by payer<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n

What ASC Leaders Should Monitor<\/h2>\r\n

A handful of metrics tell administrators whether cataract reimbursement changes are actually reaching the bottom line. Net Collection Ratio shows what percentage of contracted revenue is actually collected, not just billed. Days in AR<\/a> flags whether claims are moving cleanly or stalling in review. A denial rate specific to ophthalmology and cataract CPT codes isolates problems before they spread across the full payer mix.<\/p>\r\n

Implant cost recovery per case confirms device-intensive billing is capturing what it should. And a combined facility-plus-professional yield per case, tracked together rather than in separate silos, is the only view that shows whether a facility-rate increase is being offset by a physician-side cut.<\/p>\r\n

How ASCs Can Protect Cataract Service-Line Revenue<\/h2>\r\n

Protecting margin after a reimbursement change starts with visibility, not just volume. Facilities should reconcile posted payer rates against actual CMS and contracted fee schedules on a regular cadence, run coding audits focused on the 66982\/66984 distinction and device-intensive implant codes, add a hard prior-authorization checkpoint close to the surgery date, collect patient responsibility at point of service, and review payments against the payer contract to catch underpayments generic claim-scrubbing misses.<\/p>\r\n

This is exactly where generic medical billing services fall short. A vendor that only reports facility collections will call the 2026 update a win. Specialized RCM services<\/a> close the gap between the posted rate and the actual deposit by tracking complexity coding ratios, device-intensive charge capture tied to OR documentation, denial prevention built around the current CMS payment rules, and payment posting review, so a facility-rate increase never quietly masks a bigger loss on the physician or leakage side.<\/p>\r\n

MBC’s ophthalmology billing services<\/a> and medical billing and coding services model the combined facility-and-physician yield per cataract case on one dashboard covering Net Collection Ratio, Days in AR, and per-case implant recovery. Facilities weighing whether their current vendor covers this level of detail can review how MBC’s medical billing services pricing model<\/a> scales with case volume and complexity.<\/p>\r\n

Summary<\/h2>\r\n

The 2026 cataract reimbursement picture is more complicated than the facility-rate headline suggests. CMS raised the ASC facility payment for CPT 66984 by 3.4% to $1,255.73, but cut the physician professional payment 11% to $462.94 through a new efficiency adjustment and an indirect practice expense policy that reduces facility-based reimbursement to half of the non-facility rate.<\/p>\r\n

Layer in the everyday leakage points, coding gaps, authorization lapses, underpayments, and uncollected patient balances, and high case volume alone won’t protect margin. Facilities that track the full episode, monitor the right KPIs, and close leakage at the source are the ones that come out ahead of this transition.<\/p>\r\n

Want to see whether cataract reimbursement changes are quietly eating into your ASC’s margin?<\/strong><\/p>\r\n

Request a Facility Yield Audit<\/a> from MBC’s ophthalmology billing team to get a facility-specific breakdown of your combined facility and physician cataract yield, along with the leakage points costing you revenue today. Call 888-357-3226<\/strong><\/a> or email info@medicalbillersandcoders.com<\/strong><\/a>.<\/p>\r\n

FAQs: Cataract Reimbursement<\/h2>\r\n\r\n
\r\n
1. What is the 2026 Medicare ASC facility payment for cataract surgery (CPT 66984)?<\/strong><\/strong>\r\n

The corrected 2026 ASC facility payment is $1,255.73, up 3.4% from $1,214.31 in 2025, per the CMS OPPS\/ASC Final Rule.<\/p>\r\n<\/div>\r\n

2. Did cataract reimbursement go up or down in 2026?<\/strong><\/strong>\r\n

Both. The ASC facility rate rose 3.4%, while the physician professional payment for the same procedure fell 11%, from $521.75 to $462.94.<\/p>\r\n<\/div>\r\n

3. Why does a small reimbursement change affect ASC margin so much?<\/strong><\/strong>\r\n

Fixed costs like staffing, supplies, and instrument turnover don’t shrink with the reimbursement rate, so even a modest cut compresses margin faster than the percentage suggests, especially at high case volume.<\/p>\r\n<\/div>\r\n

4. Where does cataract-related revenue leakage usually happen?<\/strong><\/strong>\r\n

Most leakage comes from coding gaps between CPT 66982 and 66984, lapsed prior authorizations, uncaptured implant costs, unrecovered patient balances, and underpayments that go unreviewed against the payer contract.<\/p>\r\n<\/div>\r\n

5. How can ASCs protect cataract service-line revenue after a reimbursement cut?<\/strong><\/strong>\r\n

By tracking combined facility-and-physician yield per case, auditing complexity coding and implant capture, tightening authorization checkpoints, and reviewing payer payments against contracted rates, typically through ophthalmology-specific revenue cycle management.<\/p>\r\n

Sources:<\/strong><\/p>\r\n